Candriam Equities L Biotechnology Class R-H Fonds
316,68
EUR
-4,87
EUR
-1,51
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 4,07% |
| Gilead Sciences Inc | US3755581036 | 3,99% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,90% |
| Amgen Inc | US0311621009 | 3,81% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 3,54% |
| Biogen Inc | US09062X1037 | 3,46% |
| Insmed Inc | US4576693075 | 3,07% |
| Revolution Medicines Inc Ordinary Shares | US76155X1000 | 2,91% |
| Roivant Sciences Ltd Ordinary Shares | BMG762791017 | 2,81% |
| Ascendis Pharma AS | DK0060615755 | 2,32% |
| Sonstige | 66,10% |